Esketamine 0.2 mg/kg
2024-468
Approved small_molecule completed
Quick answer
Esketamine 0.2 mg/kg for Cesarean Delivery is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Cesarean Delivery
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed